Abstract: A battery enclosure assembly includes first and second pieces of an enclosure having an interior area, a plurality of fasteners joining the first and second pieces at a fastening interface, and a seal system sealing the first and second pieces at a sealing interface that is outside the plurality of fasteners relative to the interior area. The seal system including a cured gasket and a non-setting sealant.

Abstract: A motor vehicle component has two component parts made of steel with different wall thicknesses, which are arranged at an angle ? to one another and are connected by a weld seam. A joining surface at the end portion of the first component part has a bevel produced without cutting. In order to form the bevel, an end portion of an initial blank is formed without cutting. The end portion is then trimmed at the end and an abutment surface is created on the front side of the end portion. The two component parts are positioned relative to each other so that the joining surface of the first component part and the joining surface of the second component part face each other. The material-locking joining of the first component part and the second component part is achieved by a weld seam on the joining surfaces.

Abstract: A composition for treatment of African Swine Fever in swine includes avian-sourced antibodies specific for an African Swine Fever Virus isolate. These antibodies are produced by avian animals immunized against the African Swine Fever Virus isolate and mixed with a protective/reactive matrix obtained from, isolated from, or derived from, non-hyperimmune colostrum.

Abstract: The present disclosure discloses a tool (10) for assembling and disassembling a first implant component (1) and a second implant component (5).

Abstract: This disclosure relates to an anchoring member for a joint replacement, comprising a proximal interface part and a distal portion, the distal portion being configured to be anchored within bone tissue and the proximal interface part being configured for mounting a joint member of the joint replacement. The proximal interface part comprises a concave interface surface.

Abstract: A joint prosthesis comprises a first component and a second component being connected via a ball-and-socket-joint, wherein the first component comprises two outward spherical sections, at least one of the spherical sections having a projection; the ball-and-socket-joint comprises two gliding blocks each having an inward spherical section and at least one of the gliding blocks comprising a hole, the gliding blocks being attached to the second component, the outward spherical sections are in gliding engagement with the inward spherical sections of the gliding blocks so that the first component is movably attached to the second component; and the projection is inserted into one of the holes of the gliding blocks, so as to limit the mobility of the ball-and-socket-joint.

Abstract: The disclosure relates to a replacement member for a shoulder joint replacement comprising an attachment face on one side of the member, a concave joint surface on a side of the replacement member opposite to the side of the attachment face, and a circumferential face connecting the attachment face and the joint surface. A portion of the concave joint surface is connected to at least a portion of the circumferential face via a chamfered or rounded edge.

Abstract: The present invention provides an eye shield dispenser. The dispenser includes a tower portion including a front wall, a back wall, a top wall, a bottom wall, and a pair of side walls, and an insert portion located within the tower portion, the insert portion including a front wall, and a pair side of walls attached to opposite edges of the front wall. The dispenser also includes an opening in a portion of the tower portion, and at least one tab located in the opening. The tower portion and insert portion are preferably made from a single blank of material. In another embodiment, the insert portion includes a front wall, and a first wing and a second wing attached to opposite edges of the front wall.

Abstract: This invention relates to an emulsion comprising (i) an aqueous phase comprising an agrochemical A; and (ii) an oil phase comprising an agrochemical B; where either phase (i) is dispersed in phase (ii); or phase (ii) is dispersed in phase (i); agrochemical A is selected from salts of mepiquat and salts of chlormequat and mixtures of such salts; agrochemical B is trinexapac-ethyl; provided that the emulsion is not a microemulsion. It also relates to such an emulsion which is a ready mix emulsion; to use of such an emulsion for regulating plant growth; and to use of such an emulsion for preventing and/or reducing lodging of crop plants.

Abstract: A composition for treatment of African Swine Fever in swine includes avian-sourced antibodies specific for an African Swine Fever Virus isolate. These antibodies are produced by avian animals immunized against the African Swine Fever Virus isolate and mixed with a protective/reactive matrix obtained from, isolated from, or derived from, non-hyperimmune colostrum.

Abstract: A composition for treatment of mucosal infection in an animal by application to a mucous membrane includes a mixture of IgY antibodies specific for a plurality of antigens obtained from a plurality of organisms, with the plurality of organisms able to cause infection of the mucous membrane. A protective matrix including non-hyperimmune colostrum can be combined with the mixture of IgY antibodies, with the protective matrix forming at least 20% by weight of the composition.

Abstract: The composition may be used therapeutically or prophylactically and is directed toward a cluster of diarrhea-causing pathogens which cause illness or death in animals, including dogs and cats. It is prepared from a powdered egg preparation and powdered protein matrix, such as bovine colostrum. The eggs are collected from hens which have been immunized with the relevant pathogens or toxins. When the matrix includes colostrum, the powdered colostrum is derived from non-hyperimmune cattle. The vaccination strategy includes the use of antibody cross-reactivity between toxins or pathogens which cause diarrhea. For some diseases, including canine parvo, the clinical improvement using this therapeutic exceeds the standard of care. Instead of a pharmaceutical product, this composition is an orally administered food product with the same safety profile as eggs and milk.

Abstract: The composition may be used therapeutically or prophylactically and is directed toward a cluster of diarrhea-causing pathogens which cause illness or death in animals, including dogs and cats. It is prepared from a powdered egg preparation and powdered protein matrix, such as bovine colostrum. The eggs are collected from hens which have been immunized with the relevant pathogens or toxins. When the matrix includes colostrum, the powdered colostrum is derived from non-hyperimmune cattle. The vaccination strategy includes the use of antibody cross-reactivity between toxins or pathogens which cause diarrhea. For some diseases, including canine parvo, the clinical improvement using this therapeutic exceeds the standard of care. Instead of a pharmaceutical product, this composition is an orally administered food product with the same safety profile as eggs and milk.

Abstract: A remote vehicle control is activated. A throttle position on the control is maintained for a specified time. A transmission of a vehicle is engaged based on the throttle position.

Abstract: The present invention provides an eye shield dispenser. The dispenser includes a tower portion including a front wall, a back wall, a top wall, a bottom wall, and a pair of side walls, and an insert portion located within the tower portion, the insert portion including a front wall, and a pair side of walls attached to opposite edges of the front wall. The dispenser also includes an opening in a portion of the tower portion, and at least one tab located in the opening. The tower portion and insert portion are preferably made from a single blank of material. In another embodiment, the insert portion includes a front wall, and a first wing and a second wing attached to opposite edges of the front wall.

Abstract: The present invention provides an eye shield dispenser. The dispenser includes a tower portion including a front wall, a back wall, a top wall, a bottom wall, and a pair of side walls, and an insert portion located within the tower portion, the insert portion including a front wall, and a pair side of walls attached to opposite edges of the front wall. The dispenser also includes an opening in a portion of the tower portion, and at least one tab located in the opening. The tower portion and insert portion are preferably made from a single blank of material. In another embodiment, the insert portion includes a front wall, and a first wing and a second wing attached to opposite edges of the front wall.

Abstract: A remote vehicle control is activated. A throttle position on the control is maintained for a specified time. A transmission of a vehicle is engaged based on the throttle position.

Abstract: The composition may be used therapeutically or prophylactically and is directed toward a cluster of diarrhea-causing pathogens which cause illness or death in animals, including dogs and cats. It is prepared from a powdered egg preparation and powdered protein matrix, such as bovine colostrum. The eggs are collected from hens which have been immunized with the relevant pathogens or toxins. When the matrix includes colostrum, the powdered colostrum is derived from non-hyperimmune cattle. The vaccination strategy includes the use of antibody cross-reactivity between toxins or pathogens which cause diarrhea. For some diseases, including canine parvo, the clinical improvement using this therapeutic exceeds the standard of care. Instead of a pharmaceutical product, this composition is an orally administered food product with the same safety profile as eggs and milk.

Abstract: Aspects of the invention provide a dispenser-package for storing protective eyewear glasses comprising an exterior box having a top, a bottom and four sidewalls along a first length, and an interior retention mechanism for holding a plurality of protective eyewear glasses along a second length. The exterior box completely receives the interior retention mechanism and securely holds the plurality of protective eyewear glasses in place. The exterior box includes a detachable area in proximity to the bottom to allow accessing one or more of the protective eyewear glasses held in place. As a result, a more convenient and efficient way to store and distribute protective eyewear glasses encourages healthcare professionals and patients to wear them and maintain personal safety.

Abstract: Aspects of the invention provide a dispenser-package for storing protective eyewear glasses comprising an exterior box having a top, a bottom and four sidewalls along a first length, and an interior retention mechanism for holding a plurality of protective eyewear glasses along a second length. The exterior box completely receives the interior retention mechanism and securely holds the plurality of protective eyewear glasses in place. The exterior box includes a detachable area in proximity to the bottom to allow accessing one or more of the protective eyewear glasses held in place. As a result, a more convenient and efficient way to store and distribute protective eyewear glasses encourages healthcare professionals and patients to wear them and maintain personal safety.